Hls Therapeutics Stock Buy Hold or Sell Recommendation
| HLTRF Stock | USD 2.33 0.05 2.19% |
Assuming the 90 days horizon and your above-average risk tolerance, our recommendation regarding HLS Therapeutics is 'Strong Sell'. Macroaxis provides HLS Therapeutics buy-hold-or-sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding HLTRF positions.
Check out HLS Therapeutics Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. Note, we conduct extensive research on individual companies such as HLS and provide practical buy, sell, or hold advice based on investors' constraints. HLS Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.
HLS |
Execute HLS Therapeutics Buy or Sell Advice
The HLS recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on HLS Therapeutics. Macroaxis does not own or have any residual interests in HLS Therapeutics or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute HLS Therapeutics' advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Strong Sell
Market Performance | Insignificant | Details | |
Volatility | Very risky | Details | |
Hype Condition | Stale | Details | |
Current Valuation | Overvalued | Details | |
Odds Of Distress | Above Average | Details | |
Economic Sensitivity | Barely shadows the market | Details | |
Analyst Consensus | Not Available | Details | |
Reporting Quality (M-Score) | Inapplicable | Details |
HLS Therapeutics Trading Alerts and Improvement Suggestions
| HLS Therapeutics had very high historical volatility over the last 90 days | |
| HLS Therapeutics has high likelihood to experience some financial distress in the next 2 years | |
| The company reported the revenue of 60.01 M. Net Loss for the year was (13.12 M) with profit before overhead, payroll, taxes, and interest of 50.36 M. | |
| About 64.0% of the company shares are owned by institutional investors |
HLS Therapeutics Returns Distribution Density
The distribution of HLS Therapeutics' historical returns is an attempt to chart the uncertainty of HLS Therapeutics' future price movements. The chart of the probability distribution of HLS Therapeutics daily returns describes the distribution of returns around its average expected value. We use HLS Therapeutics price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of HLS Therapeutics returns is essential to provide solid investment advice for HLS Therapeutics.
| Mean Return | 0.13 | Value At Risk | -4.2 | Potential Upside | 5.41 | Standard Deviation | 3.24 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of HLS Therapeutics historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
HLS Therapeutics Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to HLS Therapeutics or Healthcare sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that HLS Therapeutics' price will be affected by overall pink sheet market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a HLS pink sheet's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over Dow Jones | 0.11 | |
β | Beta against Dow Jones | 0.05 | |
σ | Overall volatility | 3.29 | |
Ir | Information ratio | -0.0014 |
HLS Therapeutics Volatility Alert
HLS Therapeutics shows above-average downside volatility for the selected time horizon. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure HLS Therapeutics' pink sheet risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact HLS Therapeutics' pink sheet price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.HLS Therapeutics Fundamentals Vs Peers
Comparing HLS Therapeutics' fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze HLS Therapeutics' direct or indirect competition across all of the common fundamentals between HLS Therapeutics and the related equities. This way, we can detect undervalued stocks with similar characteristics as HLS Therapeutics or determine the pink sheets which would be an excellent addition to an existing portfolio. Peer analysis of HLS Therapeutics' fundamental indicators could also be used in its relative valuation, which is a method of valuing HLS Therapeutics by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare HLS Therapeutics to competition |
| Fundamentals | HLS Therapeutics | Peer Average |
| Return On Equity | -0.14 | -0.31 |
| Return On Asset | -0.0276 | -0.14 |
| Profit Margin | (0.35) % | (1.27) % |
| Operating Margin | (0.19) % | (5.51) % |
| Current Valuation | 344.73 M | 16.62 B |
| Shares Outstanding | 32.38 M | 571.82 M |
| Shares Owned By Insiders | 6.15 % | 10.09 % |
| Shares Owned By Institutions | 64.28 % | 39.21 % |
| Price To Book | 1.86 X | 9.51 X |
| Price To Sales | 4.41 X | 11.42 X |
| Revenue | 60.01 M | 9.43 B |
| Gross Profit | 50.36 M | 27.38 B |
| EBITDA | 25.41 M | 3.9 B |
| Net Income | (13.12 M) | 570.98 M |
| Cash And Equivalents | 21.16 M | 2.7 B |
| Cash Per Share | 0.65 X | 5.01 X |
| Total Debt | 84.13 M | 5.32 B |
| Debt To Equity | 0.63 % | 48.70 % |
| Current Ratio | 1.13 X | 2.16 X |
| Book Value Per Share | 4.06 X | 1.93 K |
| Cash Flow From Operations | 16.43 M | 971.22 M |
| Earnings Per Share | (0.37) X | 3.12 X |
| Number Of Employees | 92 | 18.84 K |
| Beta | 0.84 | -0.15 |
| Market Capitalization | 231.54 M | 19.03 B |
| Total Asset | 275.9 M | 29.47 B |
| Z Score | 1.2 | 8.72 |
| Annual Yield | 0.02 % | |
| Net Asset | 275.9 M | |
| Last Dividend Paid | 0.15 |
HLS Therapeutics Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as HLS . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
| Daily Balance Of Power | 9.2 T | |||
| Rate Of Daily Change | 1.02 | |||
| Day Median Price | 2.33 | |||
| Day Typical Price | 2.33 | |||
| Price Action Indicator | 0.025 | |||
| Period Momentum Indicator | 0.05 | |||
| Relative Strength Index | 45.35 |
About HLS Therapeutics Buy or Sell Advice
When is the right time to buy or sell HLS Therapeutics? Buying financial instruments such as HLS Pink Sheet isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having HLS Therapeutics in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Alcohol Thematic Idea Now
Alcohol
Companies involved in production and distribution of wines and alcoholic beverages. The Alcohol theme has 45 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Alcohol Theme or any other thematic opportunities.
| View All Next | Launch |
Other Information on Investing in HLS Pink Sheet
HLS Therapeutics financial ratios help investors to determine whether HLS Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in HLS with respect to the benefits of owning HLS Therapeutics security.